Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Criticare Systems Announces Immtech International IPO.


MILWAUKEE--(BUSINESS WIRE)--May 3, 1999--

CRITICARE SYSTEMS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ-NMS:CXIM) announced today that Immtech International, in which Criticare holds a minority interest, is now publicly trading under the symbol IMMT IMMT International Maritime Meteorological Tape (WMO)
IMMT Integrated Maintenance Management Team
IMMT International Space Station Mission Management Team
IMMT Identity Management Middle Tiers
.

Emil Soika, Criticare CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , stated, "We are excited for both companies and their respective shareholders. Immtech stock became public on April 27, 1999 at $10 per share and closed at $26-1/4 on April 30. Criticare owns approximately one million shares and has conservatively carried the value of Immtech at zero on its balance sheet."

Criticare Systems, Inc., designs, manufactures and markets cost-effective patient monitoring systems and noninvasive non·in·va·sive
adj.
1. Not penetrating the body, as by incision. Used especially of a diagnostic procedure.

2. Not invading healthy tissue.
 sensors for a wide range of hospitals and alternate health care environments throughout the world.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. Such statements refer to the company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, the risk of new and better technologies, as well as general conditions in the company's markets. It should be noted that there is risk in the investment of a biotechnology company concerning the demonstration of clinical effectiveness and time to market.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U3WI
Date:May 3, 1999
Words:204
Previous Article:Westaff's 'Job Squad' Rolls Into San Francisco Bay Area; Staffing Company Signs Up Job-Seekers With Mobile Application Station.
Next Article:FlowWise Networks Introduces Breakthrough Layer 3 Enhancement for Cisco Catalyst Switches.
Topics:



Related Articles
Criticare Systems reports first quarter operating results.
Criticare Systems announces increase in third quarter revenues; company enjoys modest growth in revenues while simultaneously transitioning to new...
Criticare Systems Announces Spin-Off of Immtech International Shares to Criticare Shareholders.
Criticare Systems Reports Increase in Second Quarter Revenues Coupled With an Almost 300% Increase in Order Backlog; Backlog Bodes Well for Third...
Criticare Systems Reports First Quarter Results.
Criticare Systems Reports Second Quarter Results.
Criticare Systems, Inc. -CSI- Reports Third Quarter Results.
IMMTECH ESTABLISHING CONSORTIUM TO TREAT LEISHMANIASIS.
CSI Announces Fourth Quarter and Year-End Results.
CSI Announces First Quarter Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles